section name header
Index
Antiplatelet Agents for Preventing Pre-Eclampsia
Antiplatelet Agents for Preventing Thrombosis after Peripheral Arterial Bypass Surgery
Antiplatelet and Anticoagulation for Patients with Prosthetic Heart Valves
Antiplatelet Drugs for Prevention of Restenosis after Peripheral Endovascular Treatment
Antiplatelet Therapy for Aneurysmal Subarachnoid Haemorrhage
Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke
Antithrombotic Drugs for Carotid Dissection
ASA for Hypertension
Clopidogrel Plus Aspirin Versus Aspirin Alone for Preventing Cardiovascular Disease in Acute Non-ST Segment Coronary Syndromes
Clopidogrel Plus Aspirin Vs Aspirin Alone for Preventing Cardiovascular Events
Combined Aspirin-Oral Anticoagulant Therapy Compared with Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
Dipyridamole for Preventing Vascular Events
Low-Dose Aspirin for Prevention of Vascular Events in Type 2 Diabetes
Medical Interventions for Traumatic Hyphema
Medical Treatment to Increase Patency of Arteriovenous Fistulae and Grafts
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
Oral Anticoagulants Vs Antiplatelet Therapy for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Stroke or TIA
Thienopyridine Derivatives (Ticlopidine, Clopidogrel) Versus Aspirin or Aspirin-Dipyridamole for Preventing Serious Vascular Events in High Risk Patients
Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation